EP4008327A1 — Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
Assigned to Amarin Pharmaceuticals Ireland Ltd · Expires 2022-06-08 · 4y expired
What this patent protects
The present invention relates to, inter alia, pharmaceutical compositions comprising eicosapenteanoic acid (EPA) and a statin, wherein the statin is suspended in EPA and wherein the composition is present in a capsule.
USPTO Abstract
The present invention relates to, inter alia, pharmaceutical compositions comprising eicosapenteanoic acid (EPA) and a statin, wherein the statin is suspended in EPA and wherein the composition is present in a capsule.
Drugs covered by this patent
- Vascepa (ICOSAPENT ETHYL) · Amarin Pharms
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.